SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001161697-19-000338
Filing Date
2019-08-20
Accepted
2019-08-19 21:37:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A AMENDMENT NO. 1 FOR 05-16-2017 sc13d.htm SC 13D/A 24990
2 AMENDMENT TO CERTIFICATE OF DESIGNATION SERIES E PREFERRED STOCK ex_99-1.htm EX-99 19744
3 CERTIFICATE OF CORRECTION ex_99-2.htm EX-99 13513
  Complete submission text file 0001161697-19-000338.txt   59579
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Subject) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89519 | Film No.: 191037763
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14001 WALDEN RD. SUITE 600 MONTGOMERY TX 77356
Business Address
Blankenship Alex K (Filed by) CIK: 0001677687 (see all company filings)

Type: SC 13D/A